In-Vitro Diagnostics (IVDs) Market: Current Scenario and

Forecast (2019-2025)

Bharat Book Bureau Provides the Trending Market Research Report on “In-Vitro
Diagnostics (IVDs)”under Healthcare Category. The report offers a collection of
superior market research, market analysis, competitive intelligence and Market
reports.

In-Vitro Diagnostics (IVDs) Market: Current Scenario and Forecast (2019-

2025): Emphasis on Product (Reagents, Instruments Services), Techniques
(Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology,
Microbiology, Point-of-Care, Hemostasis), Application (Infectious Disease,
Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Others),
End-Users (Hospitals, Clinics & Labs, Home Care, Others), Usability
(Disposable IVD Devices, Reusable IVD Devices) and Region/Country

Health care increasingly is subject to demands for better health and quality of life and
limitations on the spending required to deliver these improvements. In-vitro
diagnostics, aid in responding to such demands by enabling precise detection of health
risks and disease at earlier stages and improving treatment and disease management,
while diminishing subsequent health problems and their associated costs. Diagnostics
serve a key role in the health value chain by influencing the quality of patient care,
health outcomes, and downstream resource requirements.

From consumer-friendly at-home pregnancy and glucose monitoring tests to more

complex automated laboratory-based systems, these tests are often first-line health
decision tools. While diagnostics comprise less than 5% of hospital costs and about
1.6% of all insurance costs, their findings influence as much as 60-70% of health care
decision-making. The value of diagnostics accrues not only to clinicians and patients
but to health care managers, third-party payers and quality assurance organizations
that use diagnostic performance to measure and improve health care quality.

Request a free sample copy In-Vitro Diagnostics (IVDs) Market Report @

https://www.bharatbook.com/marketreports/sample/reports/1962152
Diagnostics have evolved with the understanding of biological systems and disease,
along with advances in science and technology. Emerging today are entirely new
categories of diagnostics, based on a full continuum of care and personalized
medicine approaches. With the potential to fundamentally alter clinical practice, these
technologies are intended to match the “right patient with the right treatment at the
right time.” As such products mature, clinicians and patients will be better able to
assess the risks and benefits of care options and customized health management
strategies to optimize individual health and quality of life.

Considering the increasing reliance on diagnostics in all phases of patient care, they
afford substantial opportunities to improve quality and efficiency. Despite the value
and potential of diagnostics, certain internal and external constraints, including
regulatory, reimbursement, market, scientific/technical and societal issues, can inhibit
the development, adoption and appropriate use of diagnostic products. Rising demand
for Point-of-Care (PoC) devices is expected to fuel the market growth further.

In addition, the introduction of advanced technologies, such as biochips and nano-

biotechnology, and miniaturization of microfluidics are expected to increase the
demand for PoC products. These advancements have enabled easy access to PoC
diagnostic tests and are likely to facilitate quick and effective test results, thereby
boosting the overall market growth.

Among all types of In-Vitro Diagnostics product type, reagents segment is expected to
dominate the market, however, the market for instruments services segment type In-
Vitro Diagnostics is expected to grow at the highest CAGR of 5.7% over the forecast
period owing to the recent advancements in IVD instruments, growth in demand for
fully automated instruments in market, as they simplify the task and provide more
accurate and reliable results.

In terms of technique type; the In-Vitro Diagnostics market is bifurcated into

immunoassay, clinical chemistry, SMBG, molecular diagnostics, hematology,
microbiology, point-of-care, and hemostasis. Among these, Molecular Diagnostics
segment is expected to grow considerably, and it is expected to grow at a CAGR of
6.3% respectively over the analyzed period owing to its increasing demand and nature
of being cost-efficient. The market is dominated by immunoassay, whereas molecular
diagnostics has emerged as one of the leading and fastest-growing sectors of the IVD
industry.

Four significant and innovative trends are currently driving the global IVD market:
POCT, automation, digitalization, and personalized medicine. In the diagnostics
industry, placing diagnostics as close as possible to the patient and healthcare
practitioners is a ground-breaking trend. POCT technologies deliver faster results as
delays caused by transportation are mitigated. Similarly, there is no need for the
preparation of clinical samples, as biochemical test results are available at the point of
care. This could help speed up clinical decision making, with improved medical
outcomes at lower costs.

On the basis of application analysis of the in-vitro diagnostics industry, Infectious

Diseases segment contributed US$ 24.24 billion by revenue and is expected to grow
with the highest CAGR of 4.89% over the forecast period through 2025. Most IVD
experiments still take place in a laboratory. Many specialties currently have fully
automated and advanced equipment, which produces results within minutes of loading
the sample.

Even the more ‘hands-on’ specialties like microbiology are gradually becoming more
streamlined as machinery is created to decrease result time and allow researchers and
pathologists to concentrate on results analysis and individual patient care. Oncology
segment is anticipated to grow at the highest CAGR of 6.0% over the forecast period
through 2025.

In-Vitro Diagnostics market is vastly competitive and is fragmented into several large
and small players forming a competitive landscape. As the concept is innovative and
emerging, each player is trying their best to dominate the marketplace. While players
have come and gone in the in vitro diagnostic landscape, Roche Diagnostics has
retained its prominence on the global front. But the Swiss giant is facing a fresh
reality, like all its other larger competitors, with growing pressure to demonstrate
medical value and a more stringent regulatory climate.

Roche Diagnostics has stood firmly in the midst of this changing scene as the number
one IVD player in the world driven by development in its biggest company segment,
Centralized and Point of Care Solutions (formerly called Professional Diagnostics).
The market for professional diagnostics (PD) is that it continues to develop healthily;
for more than 10 years it has experienced a 5% rise a year and a similar trend is
anticipated over the forecast period.

The key sub-segments of Roche as serum work area [SWA], specialty testing, point of
care- all are contributing to the growth of Roche’s IVD market. Roche will continue
to hold on firmly to the top position in the IVD market, with the company estimated
to have a substantial 17.8% market share in 2024. Following the acquisition of Alere,
Abbott is set to become the second largest IVD company, with 2024 sales forecast to
top US$ 10 billion.

Some of the key players operating in the In-Vitro Diagnostics market include Abbott
Laboratories, Inc., Becton, Dickinson and Company, Biomérieux SA, Bio-Rad
Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche Diagnostics,
Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific are among
others.

These players are working endlessly to offer consumers a better, affordable and
sustainable healthcare service across the globe.

The preceding figure gives the forecast value of global In-Vitro Diagnostics Market
from 2018 to 2025. The Global In-Vitro Diagnostics market generated a revenue of
US$ 68.92 billion in 2018 and is expected to witness a CAGR growth of 5.24%
during the forecast period 2019-2025, to reach a market size of US$ 98.18 billion by
2025.

Browse our full report with Table of Content:

https://www.bharatbook.com/marketreports/in-vitro-diagnostics-ivds-market-current-
scenario-and-forecast-2019-2025-/1962152
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports
and insights that includes latest Market Study, Market Trends & Analysis, Forecasts
Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive
coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

in-vitro diagnostics, in-vitro diagnostics market, in-vitro diagnostics market report, in-
vitro diagnostics market opportunities, in-vitro diagnostics market strategies, in-vitro
diagnostics forecast, in-vitro diagnostics market outlook, in-vitro diagnostics market
trends, in-vitro diagnostics market by product, in-vitro diagnostics market by region,
in-vitro diagnostics market study, in-vitro diagnostics market size, in-vitro diagnostics
market type, in-vitro diagnostics market share, in-vitro diagnostics market analysis,
in-vitro diagnostics market value, in-vitro diagnostics market application, in-vitro
diagnostics market growth